HistCite - Chimerism and Transplantation topic search

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2002
4301	4301 Shedarowich KS, Schwartz M, Nugent DJ Thalassemia major status post bone marrow transplant with mixed donor chimerism treated with hydroxyurea BLOOD. 2002 NOV 16; 100 (11): 34B-34B	0	0	0	0
4302	4302 Little MT, Baker JE, Sandmaier BM, Maris MB, Maloney D, et al. Kinetics of mixed chimerism in peripheral blood hematopoietic subpopulations from 120 patients after nonmyeloablative hematopoietic stem cell transplant. BLOOD. 2002 NOV 16; 100 (11): 39A-39A	1	2	0	0
4303	4303 Barker JN, Weisdorf DJ, DeFor TE, McGlave PB, Wagner JE Multiple unit unrelated donor umbilical cord blood transplantation in high risk adults with hematologic malignancies: Impact on engraftment and chimerism. BLOOD. 2002 NOV 16; 100 (11): 41A-41A	2	10	0	0
4304	4304 Barker JN, Weisdorf DJ, DeFor TE, Wagner JE Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after non-myeloablative conditioning. BLOOD. 2002 NOV 16; 100 (11): 42A-42A	1	2	0	0
4305	4305 Kean L, Manci E, Perry J, Balkan C, Coley S, et al. Chimerism and cure: Benchmarks for hematologic and pathologic correction of murine sickle cell disease with mixed RBC chimerism after nonmyeloablative bone marrow transplantation. BLOOD. 2002 NOV 16; 100 (11): 46A-46A	0	0	0	0
4306	4306 Lion T, Daxberger H, Preuner S, Fritsch G, Haas OA, et al. Increasing or persisting recipient chimerism within NK cells and T lymphocyte subsets is associated with late graft rejection in children after allogeneic stem cell transplantation. BLOOD. 2002 NOV 16; 100 (11): 114A-114A	0	0	0	0
4307	4307 Bader P, Kreyenberg H, Duckers G, Holle W, Handgretinger R, et al. Additional immunotherapy on the basis of increasing mixed chimerism - A powerful tool to prevent relapse in children transplanted for acute lymphoblastic leukemia. BLOOD. 2002 NOV 16; 100 (11): 176A-176A	0	0	0	0
4308	4308 Peggs KS, Thomson K, Geary J, Morris E, Kottaridis P, et al. Dose escalating donor lymphocyte infusions (DLI) following T-depleted reduced intensity allografting: High response rates associated with conversion to full donor chimerism (FDC) are not durable despite persistent donor chimerism. BLOOD. 2002 NOV 16; 100 (11): 177A-177A	0	0	0	0
4309	4309 Tang XW, Wu DP, Zhu ZL, Wang W Sequential and quantitative monitoring of chimerism after allogeneic hematopoitic stem cell transplantation using multiplex PCR amplification of short tandem repeat markers. BLOOD. 2002 NOV 16; 100 (11): 396B-396B	0	0	0	0
4310	4310 Dennison JD, Muralitharan S, Kannan K, Nusrat N, Rehman JU, et al. Utilizing graft versus thalassemia to abolish mixed hematopoietic chimerism: A strategy to prevent rejection post BMT for thalassemia. BLOOD. 2002 NOV 16; 100 (11): 396B-396B	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
4311	4311 Toor A, Mohideeen N, Rodriguez T, Petrowski C, Wojtowicz S, et al. Low-dose total body irradiation and Thymoglobulin (R), followed by allogeneic peripheral blood stem-cell transplantation: Mixed T-Cell chimerism associated with GVH and anti-tumor response. BLOOD. 2002 NOV 16; 100 (11): 402B-402B	0	0	0	0
4312	4312 Inoue H, Yabe H, Shimizu T, Yasuda Y, Matsumoto M, et al. Unmanipulated bone marrow transplantation from HLA 3-loci mismatched mother; contribution of long-term feto-maternal microchimerism. BLOOD. 2002 NOV 16; 100 (11): 404B-404B	0	0	0	0
4313	4313 Yunusov MY, Kuhr C, Storb R, Georges GE, Lesnikova M, et al. Marrow donor skin grafts in a canine DLA-identical model of stable mixed donor/host hematopoietic chimerism. BLOOD. 2002 NOV 16; 100 (11): 404A-405A	0	0	0	0
4314	4314 Yunusov MY, Kuhr C, Storb R, Healey P, Georges GE, et al. Survival of heterotopic small bowel transplants in DLA-identical canine model of stable mixed donor/host hematopoietic chimerism. BLOOD. 2002 NOV 16; 100 (11): 405A-405A	0	0	0	0
4315	4315 Perruche S, Kleinclauss F, Angonin R, Paris D, Herve P, et al. Mixed chimerism following non-myeloablative conditioning regimen is associated with an increased frequency of lupus-like circulating auto-antibodies and may favor occurrence of chronic graft-versus-host disease. BLOOD. 2002 NOV 16; 100 (11): 407A-408A	0	0	0	0
4316	4316 Keil F, Prinz E, Kalhs P, Mannhalter C, Nina W, et al. Rapid establishment of long term culture-initiating cells (LTC-IC) of donor origin after nonmyeloablative allogeneic hematopoietic stem cell transplantation (NST) and significant prognostic impact of donor T cell chimerism on stable engraftment and progression free survival. BLOOD. 2002 NOV 16; 100 (11): 409A-409A	0	0	0	0
4317	4317 Audigier-Valette C, Nicolini FE, Michallet AS, Le QH, Boiron JM, et al. Non myeloablative allogeneic hematopoietic stem cell transplantation (NSCT): Impact of pretransplant factors and chimerism status on transplant outcome with or without donor lymphocyte infusion (DLI). BLOOD. 2002 NOV 16; 100 (11): 409A-409A	0	0	0	0
4318	4318 Juliusson G, Karlsson K, Frodin U, Backstrom G, Malm C Subcutaneous Campath1H instead of thymoglobulin in nonmyeloablative allogeneic transplantation: Reduced acute toxicity, but delayed lymphocyte recovery leading to more mixed chimerism, more fatal infections and impaired long-term survival: A single center study of 56 patients. BLOOD. 2002 NOV 16; 100 (11): 430A-430A	0	0	0	0
4319	4319 Theil KS, Warshawsky I, Shadrach B, Serafino S, Johnston G, et al. Instability of T-cell (CD3+) mixed chimerism after day +100 in non-myeloablative allogeneic stem cell transplants. BLOOD. 2002 NOV 16; 100 (11): 432B-433B	0	0	0	0
4320	4320 Sivasubtamaniam VH, Cirenza E, Hiemenz J, Ballester OF Relapsed Hodgkin lymphoma with sustained complete remission following a transient acute graft versus host disease but in the absence of persistent donor chimerism. BLOOD. 2002 NOV 16; 100 (11): 453B-453B	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
4321	4321 Chiang AKS, Ma ESK, Jones BM, Li SYH, Chan GCF, et al. Long term immune reconstitution and cell lineage chimerism after bone marrow transplantation for severe combined immunodeficiency and Wiskott Aldrich syndrome. BLOOD. 2002 NOV 16; 100 (11): 457B-457B	0	0	0	0
4322	4322 Ha SY, Chan GCF, Lee ACW, Ma ESK, Kwong YL, et al. Treatment outcome and chimerism status in matched sib transplant for thalassemia patients using anti-thymocyte globulin (ATG) containing regimens for conditioning. BLOOD. 2002 NOV 16; 100 (11): 458B-458B	0	0	0	0
4323	4323 Ai HS, Zhao RCH, Guo M, Wang DH, Qiao JH Formed and conversion of hematopoietic chimerism in nonmyeloablative allogeneic stem cell transplantation,. BLOOD. 2002 NOV 16; 100 (11): 459B-459B	0	0	0	0
4324	4324 Buno I, Moreno-Lopez E, Jimenez-Mahillo M, Balsalobre P, Serrano D, et al. Quantification of chimerism and minimal residual disease in leukocyte lineages after T-cell depleted peripheral blood stem cell transplant (TCD-PBSCT) and donor leukocyte infusion (DLI) from non HLA- identical family donors (NIFD). BLOOD. 2002 NOV 16; 100 (11): 463B-463B	0	0	0	0
4325	4325 Doubrovina ES, Koulova L, Kersten MJ, Sokolona E, Guerrero J, et al. Preparative cytoreduction and chimeric state influence HLA restriction patterns of virus specific donor T cells developing late after HLA A, B, DR haplotype disparate T cell depleted (TCD) marrow transplant for severe combined immunodeficiency (SCID). BLOOD. 2002 NOV 16; 100 (11): 464A-464A	0	0	0	0
4326	4326 Shimazaki C, Ochiai N, Uchida R, Fuchida SI, Oknno A, et al. Non-T-cell depleted HLA haploidentical stem cell transplantation in advanced hematological malignancies based on the feto-maternal microchimerism. BLOOD. 2002 NOV 16; 100 (11): 464B-464B	0	0	0	0
4327	4327 Spyridonidis A, Schmitt-Graeff A, Carlow T, Follo M, Behringer D, et al. Epithelial microchimerism after human hematopoietic stem cell transplantation evaluated in paraffin-embedded colon biopsies. BLOOD. 2002 NOV 16; 100 (11): 514A-514A	0	0	0	0
4328	4328 Durakovic N, Fuchs EJ, Vogelsang GB, Powell JD, Luznik L Rational use of postgrafting immunossuppression for the induction of mixed hematopoietic chimerism (MC) and preservation of a graft-versus-leukemia (GVL) effect. BLOOD. 2002 NOV 16; 100 (11): 823A-824A	0	0	0	0
4329	4329 Filicko J, Brunner J, Ferber A, Grosso D, Gung C, et al. Peripheral blood chimerism predicts bone marrow chimerism following nonmyeloablative hematopoietic progenitor cell transplant. BLOOD. 2002 NOV 16; 100 (11): 838A-838A	0	0	0	0
4330	4330 Buhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease TRANSPLANTATION. 2002 NOV 27; 74 (10): 1405-1409	96	158	23	31
#	Date / Author / Journal	LCS	GCS	LCR	CR
4331	4331 Bagley J, Tian C, Sachs DH, Iacomini J T cells mediate resistance to genetically modified bone marrow in lethally irradiated recipients TRANSPLANTATION. 2002 NOV 27; 74 (10): 1454-1460	5	9	7	25
4332	4332 Gajewski JL, Ippoliti C, Ma Y, Champlin R Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor AMERICAN JOURNAL OF HEMATOLOGY. 2002 DEC; 71 (4): 311-313	3	5	13	19
4333	4333 Kuroki M, Okayama A, Nakamura S, Sasaki T, Murai K, et al. Detection of maternal-fetal microchimerism in the inflammatory lesions of patients with Sjogren's syndrome ANNALS OF THE RHEUMATIC DISEASES. 2002 DEC; 61 (12): 1041-1046	11	26	9	23
4334	4334 Valentini G, Black C Systemic sclerosis BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 2002 DEC; 16 (5): 807-816	0	24	3	50
4335	4335 Haruyama H, Ito S, Miyadai K, Takahashi T, Kawaida R, et al. Humanization of the mouse anti-Fas antibody HFE7A and crystal structure of the humanized HFE7A Fab fragment BIOLOGICAL & PHARMACEUTICAL BULLETIN. 2002 DEC; 25 (12): 1537-1545	1	11	0	43
4336	4336 Ochiai N, Shimazaki C, Fuchida S, Okano A, Sumikuma T, et al. Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia BONE MARROW TRANSPLANTATION. 2002 DEC; 30 (11): 793-796	20	21	4	10
4337	4337 Nelson RP, Logan TF, Abonour R Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma BONE MARROW TRANSPLANTATION. 2002 DEC; 30 (12): 805-812	0	2	27	101
4338	4338 Cui YZ, Hisha H, Yang GX, Fan TX, Jin T, et al. Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice BONE MARROW TRANSPLANTATION. 2002 DEC; 30 (12): 843-849	7	18	5	20
4339	4339 Massenkeil G, Rackwitz S, Genvresse I, Rosen O, Dorken B, et al. Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION. 2002 DEC; 30 (12): 899-903	6	44	6	23
4340	4340 Bayes-Genis A, Salido M, Ristol FS, Puig M, Brossa V, et al. Host cell-derived cardiomyocytes in sex-mismatch cardiac allografts CARDIOVASCULAR RESEARCH. 2002 DEC; 56 (3): 404-410	0	36	6	26
#	Date / Author / Journal	LCS	GCS	LCR	CR
4341	4341 Shalit M, Amar A, Or R Allergy development after bone marrow transplantation from a non-atopic donor CLINICAL AND EXPERIMENTAL ALLERGY. 2002 DEC; 32 (12): 1699-1701	0	10	0	20
4342	4342 Ismail M, Gibson FM, Marks K, Draycott GS, Gordon-Smith EC, et al. Combined immunocytochemistry and FISH: an improved method to study engraftment of accessory bone marrow stromal cells CLINICAL AND LABORATORY HAEMATOLOGY. 2002 DEC; 24 (6): 329-335	0	1	12	24
4343	4343 Toh HC, Spitzer TR, Preffer F, Alexander SI, McAfee S, et al. Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving non-myeloablative conditioning and a haploidentical related allogeneic bone marrow transplant CYTOKINES CELLULAR & MOLECULAR THERAPY. 2002 DEC; 7 (2): 43-47	6	6	6	12
4344	4344 Gannage M, Amoura Z, Lantz O, Piette JC, Caillat-Zucman S Feto-maternal microchimerism in connective tissue diseases EUROPEAN JOURNAL OF IMMUNOLOGY. 2002 DEC; 32 (12): 3405-3413	10	32	10	42
4345	4345 Yolcu ES, Askenasy N, Singh NP, Cherradi SEL, Shirwan H Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection IMMUNITY. 2002 DEC; 17 (6): 795-808	7	43	0	38
4346	4346 Nelson SK, Gao BF, Bose S, Rizeq M, McCord JM A novel heparin-binding, human chimeric, superoxide dismutase improves myocardial preservation and protects from ischemia-reperfusion injury JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2002 DEC; 21 (12): 1296-1303	0	17	0	31
4347	4347 Arditti FD, Greenberg R, Dekel B, Marcus H, Nagler A, et al. Human colon adenocarcinoma in the SCID/CB6 radiation chimera is susceptible to adoptive transfer of allogeneic human peripheral blood mononuclear cells JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH. 2002 DEC; 11 (6): 883-893	0	3	8	39
4348	4348 Stute N, Fehse B, Schroder J, Arps S, Adamietz P, et al. Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH. 2002 DEC; 11 (6): 977-984	7	23	8	61
4349	4349 Olivares JL, Ramos FJ, Olive T, Fillat C, Bueno M Autoimmune thyroiditis after bone marrow transplantation in a boy with Wiskott-Aldrich syndrome JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2002 DEC; 24 (9): 772-776	0	6	2	21
4350	4350 Goebel WS, Dinauer MC Retroviral-mediated gene transfer and nonmyeloablative conditioning: Studies in a murine X-linked chronic granulomatous disease model JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2002 DEC; 24 (9): 787-790	0	5	5	40
#	Date / Author / Journal	LCS	GCS	LCR	CR
4351	4351 Arnold R, Massenkeil G, Bornhauser M, Ehninger G, Beelen DW, et al. Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease LEUKEMIA. 2002 DEC; 16 (12): 2423-2428	5	49	11	17
4352	4352 Tedeschi A, Cairoli R, Marenco P, Nosari A, Tresoldi E, et al. Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation LEUKEMIA. 2002 DEC; 16 (12): 2455-2456	0	3	0	7
4353	4353 Kren BT, Chowdhury NR, Chowdhury JR, Steer CJ Gene therapy as an alternative to liver transplantation LIVER TRANSPLANTATION. 2002 DEC; 8 (12): 1089-1108	0	16	4	171
4354	4354 Hutchinson K, Kopko PM, Muto KN, Tuscano J, O'Donnell RT, et al. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation TRANSFUSION. 2002 DEC; 42 (12): 1567-1572	0	11	2	15
4355	4355 Yunusov MY, Kuhr C, Georges GE, Sale GE, Spector M, et al. Survival of small bowel transplants in canine mixed hematopoietic chimeras: Preliminary results TRANSPLANTATION PROCEEDINGS. 2002 DEC; 34 (8): 3366-3367	5	6	5	8
4356	4356 Slavin S Non-myeloablative stem cell transplantation for induction of host-versus-graft tolerance for adoptive immunotherapy of malignant and nonmalignant diseases and towards transplantation of organ allografts TRANSPLANTATION PROCEEDINGS. 2002 DEC; 34 (8): 3371-3373	1	2	10	21
4357	4357 Kroger N, Sayer HG, Schwerdtfeger R, Kiehl M, Nagler A, et al. Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality BLOOD. 2002 DEC 1; 100 (12): 3919-3924	14	115	9	33
4358	4358 Bradley HL, Hawley TS, Bunting KD Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells BLOOD. 2002 DEC 1; 100 (12): 3983-3989	0	44	1	44
4359	4359 Reuter U, Roesler J, Thiede C, Schulz A, Classen CF, et al. Correction of complete interferon-gamma receptor 1 deficiency by bone marrow transplantation BLOOD. 2002 DEC 1; 100 (12): 4234-4235	1	14	1	10
4360	4360 Liu TM, Yu XM, Ye YZ, Zhou JF, Wang ZW, et al. Factors affecting the efficiency of somatic cell nuclear transplantation in the fish embryo JOURNAL OF EXPERIMENTAL ZOOLOGY. 2002 DEC 1; 293 (7): 719-725	0	7	0	31
#	Date / Author / Journal	LCS	GCS	LCR	CR
4361	4361 Bhattacharyya S, Chawla A, Smith K, Zhou YG, Talib S, et al. Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice JOURNAL OF IMMUNOLOGY. 2002 DEC 1; 169 (11): 6133-6140	12	22	9	22
4362	4362 Strutz N, Villmann C, Breitinger HG, Werner M, Wenthold RJ, et al. Kainate-binding proteins are rendered functional ion channels upon transplantation of two short pore-flanking domains from a kainate receptor JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 48035-48042	2	8	2	40
4363	4363 Yakubenko VP, Lishko VK, Lam SCT, Ugarova TP A molecular basis for integrin alpha(M)beta(2) ligand binding promiscuity JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 48635-48642	0	42	0	64
4364	4364 Robinson SP, Goldstone AH, Mackinnon S, Carella A, Russell N, et al. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation BLOOD. 2002 DEC 15; 100 (13): 4310-4316	16	196	11	22
4365	4365 Gleit ZL, Fuchimoto Y, Yamada K, Melendy E, Scheier-Dolberg R, et al. Variable relationship between chimerism and tolerance after hematopoietic cell transplantation without myelosuppressive conditioning TRANSPLANTATION. 2002 DEC 15; 74 (11): 1535-1544	17	19	18	24
4366	4366 Granger DK, Briedenbach WC, Pidwell DJ, Jones JW, Baxter-Lowe LA, et al. Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand TRANSPLANTATION. 2002 DEC 15; 74 (11): 1624-1630	14	24	9	21
4367	4367 Leonard PA, Woodside KJ, Gugliuzza KK, Sur S, Daller JA Safe administration of a humanized murine antibody after anaphylaxis to a chimeric murine antibody TRANSPLANTATION. 2002 DEC 27; 74 (12): 1697-1700	3	15	3	23
2003
4368	4368 Thiele J, Wickenhauser C, Kvasnicka HM, Varus E, Schneider C, et al. Mixed chimerism of erythro- and megakaryopoiesis following allogeneic bone marrow transplantation ACTA HAEMATOLOGICA. 2003; 109 (4): 176-183	7	7	21	39
4369	4369 den Dulk M, Bishop GA Immune mechanisms contributing to spontaneous acceptance of liver transplants in rodents and their potential for clinical transplantation ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. 2003; 51 (1): 29-44	0	4	29	143
4370	4370 Keown PA, Balshaw R, Khorasheh S, Chong M, Marra C, et al. Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation BIODRUGS. 2003; 17 (4): 271-279	5	21	8	37
#	Date / Author / Journal	LCS	GCS	LCR	CR
4371	4371 Misra P, Datta SK, Chakrabarty D Mutation in flower colour and shape of Chrysanthemum morifolium induced by gamma-radiation BIOLOGIA PLANTARUM. 2003; 47 (1): 153-156	0	9	0	10
4372	4372 Sefrioui H, Donahue J, Gilpin EA, Srivastava AS, Carrier E Tolerance and immunity following in utero transplantation of allogeneic fetal liver cells: The cytokine shift CELL TRANSPLANTATION. 2003; 12 (1): 75-82	3	7	19	48
4373	4373 Newman H, Reems JA, Rigley TH, Bravo D, Strong DM Donor age and gender are the strongest predictors of marrow recovery from cadaveric vertebral bodies CELL TRANSPLANTATION. 2003; 12 (1): 83-90	0	4	8	17
4374	4374 Guo ZG, Pan YS, Luo B, Sozen H, Sutherland DER, et al. The role of chimerism on inducing tolerance to islet allografts in chemically induced diabetic mice and in spontaneously diabetic NOD mice CELL TRANSPLANTATION. 2003; 12 (2): 161-162	0	1	0	0
4375	4375 Keene CD, Ortiz-Gonzalez XR, Jiang YH, Largaespada DA, Verfaillie CM, et al. Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos CELL TRANSPLANTATION. 2003; 12 (3): 201-213	0	60	1	27
4376	4376 Huwer H, Winning J, Vollmar B, Welter C, Lohbach C, et al. Long-term cell survival and hemodynamic improvements after neonatal cardiomyocyte and satellite cell transplantation into healed myocardial cryoinfarcted lesions in rats CELL TRANSPLANTATION. 2003; 12 (7): 757-767	0	21	2	50
4377	4377 Abken H, Hombach A, Heuser C Immune response manipulation: Recombinant immunoreceptors endow T-cells with predefined specificity CURRENT PHARMACEUTICAL DESIGN. 2003; 9 (24): 1992-2001	1	17	18	101
4378	4378 Pule M, Finney H, Lawson A Artificial T-cell receptors CYTOTHERAPY. 2003; 5 (3): 211-226	3	17	13	109
4379	4379 Lowder JN, Whelton P Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact CYTOTHERAPY. 2003; 5 (5): 377-390	0	10	0	45
4380	4380 Schriever F, Huhn D New directions in the diagnosis and treatment of chronic lymphocytic leukaemia DRUGS. 2003; 63 (10): 953-969	0	19	3	106
#	Date / Author / Journal	LCS	GCS	LCR	CR
4381	4381 Chapman TM, Keating GM Basifiximab - A review of its use as induction therapy in renal transplantation DRUGS. 2003; 63 (24): 2803-2835	3	45	22	85
4382	4382 Ensminger SM, Spriewald BM, Fischlein T, Weyand M, Morris PJ, et al. Mouse endothelial CD40 expression does not play a role during the development of transplant arteriosclerosis ENDOTHELIUM-NEW YORK. 2003; 10 (2): 111-117	0	1	3	29
4383	4383 Arai K Genetics of the loach, Misgurnus anguillicaudatus: recent progress and perspective FOLIA BIOLOGICA-KRAKOW. 2003; 51: 107-117	1	26	1	69
4384	4384 Nakagawa M, Ueno K Pigmentation in chimeric loach produced by cell transplantation with genetically pigmented and orange embryos FOLIA BIOLOGICA-KRAKOW. 2003; 51: 119-123	0	0	6	22
4385	4385 Reisner Y, Gur H, Reich-Zeliger S, Martelli MF, Bachar-Lustig E Hematopoietic stem cell transplantation across major genetic barriers - Tolerance induction by megadose CD34 cells and other veto cells HEMATOPOIETIC STEM CELLS 2002: GENETICS AND FUNCTION. 2003; 996: 72-79	2	11	7	23
4386	4386 Theodoro A, Barreto CB, Gusmao PM, Von Held J, Cruz AD, et al. Influence of first-wave derived T lymphocytes in the long term functional reconstitution of allogeneic T cell deficient hosts IMMUNOBIOLOGY. 2003; 207 (3): 207-215	0	0	5	27
4387	4387 Maris M, Storb R The transplantation of hematopoietic stem cells after non-myeloablative conditioning - A cellular therapeutic approach to hematologic and genetic diseases IMMUNOLOGIC RESEARCH. 2003; 28 (1): 13-24	6	22	24	52
4388	4388 Ageyama N, Kimikawa M, Eguchi K, Ono F, Shibata H, et al. Modification of the leukapheresis procedure for use in rhesus monkeys (Macaca mulata) JOURNAL OF CLINICAL APHERESIS. 2003; 18 (1): 26-31	0	5	4	27
4389	4389 Kvasnicka HM, Wickenhauser C, Thiele J, Varus E, Hamm K, et al. Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia LEUKEMIA & LYMPHOMA. 2003; 44 (2): 321-328	9	14	17	73
4390	4390 Buno I, Anta B, Moreno-Lopez E, Balsalobre P, Balas A, et al. Lineage-specific chimaerism quantification after T-cell depleted peripheral blood stem cell transplantation LEUKEMIA & LYMPHOMA. 2003; 44 (4): 659-667	5	7	9	24
#	Date / Author / Journal	LCS	GCS	LCR	CR
4391	4391 Juliusson G, Karlsson K, Malm C, Frodin U, Mollen AS, et al. Adjusted conditioning for allogeneic transplantation in a single center setting: Mixed chimerism heralds relapse LEUKEMIA & LYMPHOMA. 2003; 44 (4): 669-679	4	4	8	47
4392	4392 Kolar GR, Capra JD The NOD/SCID chimeric mouse model of human B cell development: studies on the VH4 family immunoglobulin repertoire and implications for SLE LUPUS. 2003; 12 (3): 158-162	0	2	3	28
4393	4393 Carpenter PA, Sanders JE Steroid-refractory graft-vs.-host disease: past, present and future PEDIATRIC TRANSPLANTATION. 2003; 7: 19-31	0	24	5	81
4394	4394 Spitzer TR The expanding applications of non-myeloablative stem cell transplantation PEDIATRIC TRANSPLANTATION. 2003; 7: 95-100	4	9	21	27
4395	4395 Hasegawa T, Imai H, Miki S Cost evaluation of basiliximab treatment for renal transplant patients in Japan PHARMACOECONOMICS. 2003; 21 (11): 791-806	1	4	3	41
4396	4396 Down JD, White-Scharf ME Reprogramming immune responses: Enabling cellular therapies and regenerative medicine STEM CELLS. 2003; 21 (1): 21-32	4	16	43	111
4397	4397 Askenasy N, Yoleuk ES, Shirwan H, Wang ZL, Farkas DL Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients STEM CELLS. 2003; 21 (2): 200-207	3	10	19	45
4398	4398 Nitsche A, Junghahn I, Thulke S, Aumann J, Radonic A, et al. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice STEM CELLS. 2003; 21 (2): 236-244	0	13	2	29
4399	4399 Shields LE, Gaur LK, Gough M, Potter J, Sieverkropp A, et al. In utero hematopoietic stem cell transplantation in nonhuman primates: The role of T cells STEM CELLS. 2003; 21 (3): 304-314	17	26	13	53
4400	4400 Zorina TD, Subbotin VM, Bertera S, Alexander AM, Haluszczak C, et al. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes STEM CELLS. 2003; 21 (4): 377-388	13	74	8	41

Date / Author / Journal

LCS

GCS

LCR

2002

4301

4301 Shedarowich KS, Schwartz M, Nugent DJ

Thalassemia major status post bone marrow transplant with mixed donor chimerism treated with hydroxyurea

BLOOD. 2002 NOV 16; 100 (11): 34B-34B

4302

4302 Little MT, Baker JE, Sandmaier BM, Maris MB, Maloney D, et al.

Kinetics of mixed chimerism in peripheral blood hematopoietic subpopulations from 120 patients after nonmyeloablative hematopoietic stem cell transplant.

BLOOD. 2002 NOV 16; 100 (11): 39A-39A

4303

4303 Barker JN, Weisdorf DJ, DeFor TE, McGlave PB, Wagner JE

Multiple unit unrelated donor umbilical cord blood transplantation in high risk adults with hematologic malignancies: Impact on engraftment and chimerism.

BLOOD. 2002 NOV 16; 100 (11): 41A-41A

4304

4304 Barker JN, Weisdorf DJ, DeFor TE, Wagner JE

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after non-myeloablative conditioning.

BLOOD. 2002 NOV 16; 100 (11): 42A-42A

4305

4305 Kean L, Manci E, Perry J, Balkan C, Coley S, et al.

Chimerism and cure: Benchmarks for hematologic and pathologic correction of murine sickle cell disease with mixed RBC chimerism after nonmyeloablative bone marrow transplantation.

BLOOD. 2002 NOV 16; 100 (11): 46A-46A

4306

4306 Lion T, Daxberger H, Preuner S, Fritsch G, Haas OA, et al.

Increasing or persisting recipient chimerism within NK cells and T lymphocyte subsets is associated with late graft rejection in children after allogeneic stem cell transplantation.

BLOOD. 2002 NOV 16; 100 (11): 114A-114A

4307

4307 Bader P, Kreyenberg H, Duckers G, Holle W, Handgretinger R, et al.

Additional immunotherapy on the basis of increasing mixed chimerism - A powerful tool to prevent relapse in children transplanted for acute lymphoblastic leukemia.

BLOOD. 2002 NOV 16; 100 (11): 176A-176A

4308

4308 Peggs KS, Thomson K, Geary J, Morris E, Kottaridis P, et al.

Dose escalating donor lymphocyte infusions (DLI) following T-depleted reduced intensity allografting: High response rates associated with conversion to full donor chimerism (FDC) are not durable despite persistent donor chimerism.

BLOOD. 2002 NOV 16; 100 (11): 177A-177A

4309

4309 Tang XW, Wu DP, Zhu ZL, Wang W

Sequential and quantitative monitoring of chimerism after allogeneic hematopoitic stem cell transplantation using multiplex PCR amplification of short tandem repeat markers.

BLOOD. 2002 NOV 16; 100 (11): 396B-396B

4310

4310 Dennison JD, Muralitharan S, Kannan K, Nusrat N, Rehman JU, et al.

Utilizing graft versus thalassemia to abolish mixed hematopoietic chimerism: A strategy to prevent rejection post BMT for thalassemia.

BLOOD. 2002 NOV 16; 100 (11): 396B-396B

Date / Author / Journal

LCS

GCS

LCR

4311

4311 Toor A, Mohideeen N, Rodriguez T, Petrowski C, Wojtowicz S, et al.

Low-dose total body irradiation and Thymoglobulin (R), followed by allogeneic peripheral blood stem-cell transplantation: Mixed T-Cell chimerism associated with GVH and anti-tumor response.

BLOOD. 2002 NOV 16; 100 (11): 402B-402B

4312

4312 Inoue H, Yabe H, Shimizu T, Yasuda Y, Matsumoto M, et al.

Unmanipulated bone marrow transplantation from HLA 3-loci mismatched mother; contribution of long-term feto-maternal microchimerism.

BLOOD. 2002 NOV 16; 100 (11): 404B-404B

4313

4313 Yunusov MY, Kuhr C, Storb R, Georges GE, Lesnikova M, et al.

Marrow donor skin grafts in a canine DLA-identical model of stable mixed donor/host hematopoietic chimerism.

BLOOD. 2002 NOV 16; 100 (11): 404A-405A

4314

4314 Yunusov MY, Kuhr C, Storb R, Healey P, Georges GE, et al.

Survival of heterotopic small bowel transplants in DLA-identical canine model of stable mixed donor/host hematopoietic chimerism.

BLOOD. 2002 NOV 16; 100 (11): 405A-405A

4315

4315 Perruche S, Kleinclauss F, Angonin R, Paris D, Herve P, et al.

Mixed chimerism following non-myeloablative conditioning regimen is associated with an increased frequency of lupus-like circulating auto-antibodies and may favor occurrence of chronic graft-versus-host disease.

BLOOD. 2002 NOV 16; 100 (11): 407A-408A

4316

4316 Keil F, Prinz E, Kalhs P, Mannhalter C, Nina W, et al.

Rapid establishment of long term culture-initiating cells (LTC-IC) of donor origin after nonmyeloablative allogeneic hematopoietic stem cell transplantation (NST) and significant prognostic impact of donor T cell chimerism on stable engraftment and progression free survival.

BLOOD. 2002 NOV 16; 100 (11): 409A-409A

4317

4317 Audigier-Valette C, Nicolini FE, Michallet AS, Le QH, Boiron JM, et al.

Non myeloablative allogeneic hematopoietic stem cell transplantation (NSCT): Impact of pretransplant factors and chimerism status on transplant outcome with or without donor lymphocyte infusion (DLI).

BLOOD. 2002 NOV 16; 100 (11): 409A-409A

4318

4318 Juliusson G, Karlsson K, Frodin U, Backstrom G, Malm C

Subcutaneous Campath1H instead of thymoglobulin in nonmyeloablative allogeneic transplantation: Reduced acute toxicity, but delayed lymphocyte recovery leading to more mixed chimerism, more fatal infections and impaired long-term survival: A single center study of 56 patients.

BLOOD. 2002 NOV 16; 100 (11): 430A-430A

4319

4319 Theil KS, Warshawsky I, Shadrach B, Serafino S, Johnston G, et al.

Instability of T-cell (CD3+) mixed chimerism after day +100 in non-myeloablative allogeneic stem cell transplants.

BLOOD. 2002 NOV 16; 100 (11): 432B-433B

4320

4320 Sivasubtamaniam VH, Cirenza E, Hiemenz J, Ballester OF

Relapsed Hodgkin lymphoma with sustained complete remission following a transient acute graft versus host disease but in the absence of persistent donor chimerism.

BLOOD. 2002 NOV 16; 100 (11): 453B-453B

Date / Author / Journal

LCS

GCS

LCR

4321

4321 Chiang AKS, Ma ESK, Jones BM, Li SYH, Chan GCF, et al.

Long term immune reconstitution and cell lineage chimerism after bone marrow transplantation for severe combined immunodeficiency and Wiskott Aldrich syndrome.

BLOOD. 2002 NOV 16; 100 (11): 457B-457B

4322

4322 Ha SY, Chan GCF, Lee ACW, Ma ESK, Kwong YL, et al.

Treatment outcome and chimerism status in matched sib transplant for thalassemia patients using anti-thymocyte globulin (ATG) containing regimens for conditioning.

BLOOD. 2002 NOV 16; 100 (11): 458B-458B

4323

4323 Ai HS, Zhao RCH, Guo M, Wang DH, Qiao JH

Formed and conversion of hematopoietic chimerism in nonmyeloablative allogeneic stem cell transplantation,.

BLOOD. 2002 NOV 16; 100 (11): 459B-459B

4324

4324 Buno I, Moreno-Lopez E, Jimenez-Mahillo M, Balsalobre P, Serrano D, et al.

Quantification of chimerism and minimal residual disease in leukocyte lineages after T-cell depleted peripheral blood stem cell transplant (TCD-PBSCT) and donor leukocyte infusion (DLI) from non HLA- identical family donors (NIFD).

BLOOD. 2002 NOV 16; 100 (11): 463B-463B

4325

4325 Doubrovina ES, Koulova L, Kersten MJ, Sokolona E, Guerrero J, et al.

Preparative cytoreduction and chimeric state influence HLA restriction patterns of virus specific donor T cells developing late after HLA A, B, DR haplotype disparate T cell depleted (TCD) marrow transplant for severe combined immunodeficiency (SCID).

BLOOD. 2002 NOV 16; 100 (11): 464A-464A

4326

4326 Shimazaki C, Ochiai N, Uchida R, Fuchida SI, Oknno A, et al.

Non-T-cell depleted HLA haploidentical stem cell transplantation in advanced hematological malignancies based on the feto-maternal microchimerism.

BLOOD. 2002 NOV 16; 100 (11): 464B-464B

4327

4327 Spyridonidis A, Schmitt-Graeff A, Carlow T, Follo M, Behringer D, et al.

Epithelial microchimerism after human hematopoietic stem cell transplantation evaluated in paraffin-embedded colon biopsies.

BLOOD. 2002 NOV 16; 100 (11): 514A-514A

4328

4328 Durakovic N, Fuchs EJ, Vogelsang GB, Powell JD, Luznik L

Rational use of postgrafting immunossuppression for the induction of mixed hematopoietic chimerism (MC) and preservation of a graft-versus-leukemia (GVL) effect.

BLOOD. 2002 NOV 16; 100 (11): 823A-824A

4329

4329 Filicko J, Brunner J, Ferber A, Grosso D, Gung C, et al.

Peripheral blood chimerism predicts bone marrow chimerism following nonmyeloablative hematopoietic progenitor cell transplant.

BLOOD. 2002 NOV 16; 100 (11): 838A-838A

4330

4330 Buhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, et al.

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease

TRANSPLANTATION. 2002 NOV 27; 74 (10): 1405-1409

158

Date / Author / Journal

LCS

GCS

LCR

4331

4331 Bagley J, Tian C, Sachs DH, Iacomini J

T cells mediate resistance to genetically modified bone marrow in lethally irradiated recipients

TRANSPLANTATION. 2002 NOV 27; 74 (10): 1454-1460

4332

4332 Gajewski JL, Ippoliti C, Ma Y, Champlin R

Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor

AMERICAN JOURNAL OF HEMATOLOGY. 2002 DEC; 71 (4): 311-313

4333

4333 Kuroki M, Okayama A, Nakamura S, Sasaki T, Murai K, et al.

Detection of maternal-fetal microchimerism in the inflammatory lesions of patients with Sjogren's syndrome

ANNALS OF THE RHEUMATIC DISEASES. 2002 DEC; 61 (12): 1041-1046

4334

4334 Valentini G, Black C

Systemic sclerosis

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 2002 DEC; 16 (5): 807-816

4335

4335 Haruyama H, Ito S, Miyadai K, Takahashi T, Kawaida R, et al.

Humanization of the mouse anti-Fas antibody HFE7A and crystal structure of the humanized HFE7A Fab fragment

BIOLOGICAL & PHARMACEUTICAL BULLETIN. 2002 DEC; 25 (12): 1537-1545

4336

4336 Ochiai N, Shimazaki C, Fuchida S, Okano A, Sumikuma T, et al.

Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia

BONE MARROW TRANSPLANTATION. 2002 DEC; 30 (11): 793-796

4337

4337 Nelson RP, Logan TF, Abonour R

Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma

BONE MARROW TRANSPLANTATION. 2002 DEC; 30 (12): 805-812

101

4338

4338 Cui YZ, Hisha H, Yang GX, Fan TX, Jin T, et al.

Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice

BONE MARROW TRANSPLANTATION. 2002 DEC; 30 (12): 843-849

4339

4339 Massenkeil G, Rackwitz S, Genvresse I, Rosen O, Dorken B, et al.

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation

BONE MARROW TRANSPLANTATION. 2002 DEC; 30 (12): 899-903

4340

4340 Bayes-Genis A, Salido M, Ristol FS, Puig M, Brossa V, et al.

Host cell-derived cardiomyocytes in sex-mismatch cardiac allografts

CARDIOVASCULAR RESEARCH. 2002 DEC; 56 (3): 404-410

Date / Author / Journal

LCS

GCS

LCR

4341

4341 Shalit M, Amar A, Or R

Allergy development after bone marrow transplantation from a non-atopic donor

CLINICAL AND EXPERIMENTAL ALLERGY. 2002 DEC; 32 (12): 1699-1701

4342

4342 Ismail M, Gibson FM, Marks K, Draycott GS, Gordon-Smith EC, et al.

Combined immunocytochemistry and FISH: an improved method to study engraftment of accessory bone marrow stromal cells

CLINICAL AND LABORATORY HAEMATOLOGY. 2002 DEC; 24 (6): 329-335

4343

4343 Toh HC, Spitzer TR, Preffer F, Alexander SI, McAfee S, et al.

Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving non-myeloablative conditioning and a haploidentical related allogeneic bone marrow transplant

CYTOKINES CELLULAR & MOLECULAR THERAPY. 2002 DEC; 7 (2): 43-47

4344

4344 Gannage M, Amoura Z, Lantz O, Piette JC, Caillat-Zucman S

Feto-maternal microchimerism in connective tissue diseases

EUROPEAN JOURNAL OF IMMUNOLOGY. 2002 DEC; 32 (12): 3405-3413

4345

4345 Yolcu ES, Askenasy N, Singh NP, Cherradi SEL, Shirwan H

Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection

IMMUNITY. 2002 DEC; 17 (6): 795-808

4346

4346 Nelson SK, Gao BF, Bose S, Rizeq M, McCord JM

A novel heparin-binding, human chimeric, superoxide dismutase improves myocardial preservation and protects from ischemia-reperfusion injury

JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2002 DEC; 21 (12): 1296-1303

4347

4347 Arditti FD, Greenberg R, Dekel B, Marcus H, Nagler A, et al.

Human colon adenocarcinoma in the SCID/CB6 radiation chimera is susceptible to adoptive transfer of allogeneic human peripheral blood mononuclear cells

JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH. 2002 DEC; 11 (6): 883-893

4348

4348 Stute N, Fehse B, Schroder J, Arps S, Adamietz P, et al.

Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant

JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH. 2002 DEC; 11 (6): 977-984

4349

4349 Olivares JL, Ramos FJ, Olive T, Fillat C, Bueno M

Autoimmune thyroiditis after bone marrow transplantation in a boy with Wiskott-Aldrich syndrome

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2002 DEC; 24 (9): 772-776

4350

4350 Goebel WS, Dinauer MC

Retroviral-mediated gene transfer and nonmyeloablative conditioning: Studies in a murine X-linked chronic granulomatous disease model

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2002 DEC; 24 (9): 787-790

Date / Author / Journal

LCS

GCS

LCR

4351

4351 Arnold R, Massenkeil G, Bornhauser M, Ehninger G, Beelen DW, et al.

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease

LEUKEMIA. 2002 DEC; 16 (12): 2423-2428

4352

4352 Tedeschi A, Cairoli R, Marenco P, Nosari A, Tresoldi E, et al.

Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation

LEUKEMIA. 2002 DEC; 16 (12): 2455-2456

4353

4353 Kren BT, Chowdhury NR, Chowdhury JR, Steer CJ

Gene therapy as an alternative to liver transplantation

LIVER TRANSPLANTATION. 2002 DEC; 8 (12): 1089-1108

171

4354

4354 Hutchinson K, Kopko PM, Muto KN, Tuscano J, O'Donnell RT, et al.

Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation

TRANSFUSION. 2002 DEC; 42 (12): 1567-1572

4355

4355 Yunusov MY, Kuhr C, Georges GE, Sale GE, Spector M, et al.

Survival of small bowel transplants in canine mixed hematopoietic chimeras: Preliminary results

TRANSPLANTATION PROCEEDINGS. 2002 DEC; 34 (8): 3366-3367

4356

4356 Slavin S

Non-myeloablative stem cell transplantation for induction of host-versus-graft tolerance for adoptive immunotherapy of malignant and nonmalignant diseases and towards transplantation of organ allografts

TRANSPLANTATION PROCEEDINGS. 2002 DEC; 34 (8): 3371-3373

4357

4357 Kroger N, Sayer HG, Schwerdtfeger R, Kiehl M, Nagler A, et al.

BLOOD. 2002 DEC 1; 100 (12): 3919-3924

115

4358

4358 Bradley HL, Hawley TS, Bunting KD

Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells

BLOOD. 2002 DEC 1; 100 (12): 3983-3989

4359

4359 Reuter U, Roesler J, Thiede C, Schulz A, Classen CF, et al.

Correction of complete interferon-gamma receptor 1 deficiency by bone marrow transplantation

BLOOD. 2002 DEC 1; 100 (12): 4234-4235

4360

4360 Liu TM, Yu XM, Ye YZ, Zhou JF, Wang ZW, et al.

Factors affecting the efficiency of somatic cell nuclear transplantation in the fish embryo

JOURNAL OF EXPERIMENTAL ZOOLOGY. 2002 DEC 1; 293 (7): 719-725

Date / Author / Journal

LCS

GCS

LCR

4361

4361 Bhattacharyya S, Chawla A, Smith K, Zhou YG, Talib S, et al.

Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice

JOURNAL OF IMMUNOLOGY. 2002 DEC 1; 169 (11): 6133-6140

4362

4362 Strutz N, Villmann C, Breitinger HG, Werner M, Wenthold RJ, et al.

Kainate-binding proteins are rendered functional ion channels upon transplantation of two short pore-flanking domains from a kainate receptor

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 48035-48042

4363

4363 Yakubenko VP, Lishko VK, Lam SCT, Ugarova TP

A molecular basis for integrin alpha(M)beta(2) ligand binding promiscuity

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 DEC 13; 277 (50): 48635-48642

4364

4364 Robinson SP, Goldstone AH, Mackinnon S, Carella A, Russell N, et al.

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

BLOOD. 2002 DEC 15; 100 (13): 4310-4316

196

4365

4365 Gleit ZL, Fuchimoto Y, Yamada K, Melendy E, Scheier-Dolberg R, et al.

Variable relationship between chimerism and tolerance after hematopoietic cell transplantation without myelosuppressive conditioning

TRANSPLANTATION. 2002 DEC 15; 74 (11): 1535-1544

4366

4366 Granger DK, Briedenbach WC, Pidwell DJ, Jones JW, Baxter-Lowe LA, et al.

Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand

TRANSPLANTATION. 2002 DEC 15; 74 (11): 1624-1630

4367

4367 Leonard PA, Woodside KJ, Gugliuzza KK, Sur S, Daller JA

Safe administration of a humanized murine antibody after anaphylaxis to a chimeric murine antibody

TRANSPLANTATION. 2002 DEC 27; 74 (12): 1697-1700

2003

4368

4368 Thiele J, Wickenhauser C, Kvasnicka HM, Varus E, Schneider C, et al.

Mixed chimerism of erythro- and megakaryopoiesis following allogeneic bone marrow transplantation

ACTA HAEMATOLOGICA. 2003; 109 (4): 176-183

4369

4369 den Dulk M, Bishop GA

Immune mechanisms contributing to spontaneous acceptance of liver transplants in rodents and their potential for clinical transplantation

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. 2003; 51 (1): 29-44

143

4370

4370 Keown PA, Balshaw R, Khorasheh S, Chong M, Marra C, et al.

Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation

BIODRUGS. 2003; 17 (4): 271-279

Date / Author / Journal

LCS

GCS

LCR

4371

4371 Misra P, Datta SK, Chakrabarty D

Mutation in flower colour and shape of Chrysanthemum morifolium induced by gamma-radiation

BIOLOGIA PLANTARUM. 2003; 47 (1): 153-156

4372

4372 Sefrioui H, Donahue J, Gilpin EA, Srivastava AS, Carrier E

Tolerance and immunity following in utero transplantation of allogeneic fetal liver cells: The cytokine shift

CELL TRANSPLANTATION. 2003; 12 (1): 75-82

4373

4373 Newman H, Reems JA, Rigley TH, Bravo D, Strong DM

Donor age and gender are the strongest predictors of marrow recovery from cadaveric vertebral bodies

CELL TRANSPLANTATION. 2003; 12 (1): 83-90

4374

4374 Guo ZG, Pan YS, Luo B, Sozen H, Sutherland DER, et al.

The role of chimerism on inducing tolerance to islet allografts in chemically induced diabetic mice and in spontaneously diabetic NOD mice

CELL TRANSPLANTATION. 2003; 12 (2): 161-162

4375

4375 Keene CD, Ortiz-Gonzalez XR, Jiang YH, Largaespada DA, Verfaillie CM, et al.

Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos

CELL TRANSPLANTATION. 2003; 12 (3): 201-213

4376

4376 Huwer H, Winning J, Vollmar B, Welter C, Lohbach C, et al.

Long-term cell survival and hemodynamic improvements after neonatal cardiomyocyte and satellite cell transplantation into healed myocardial cryoinfarcted lesions in rats

CELL TRANSPLANTATION. 2003; 12 (7): 757-767

4377

4377 Abken H, Hombach A, Heuser C

Immune response manipulation: Recombinant immunoreceptors endow T-cells with predefined specificity

CURRENT PHARMACEUTICAL DESIGN. 2003; 9 (24): 1992-2001

101

4378

4378 Pule M, Finney H, Lawson A

Artificial T-cell receptors

CYTOTHERAPY. 2003; 5 (3): 211-226

109

4379

4379 Lowder JN, Whelton P

Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact

CYTOTHERAPY. 2003; 5 (5): 377-390

4380

4380 Schriever F, Huhn D

New directions in the diagnosis and treatment of chronic lymphocytic leukaemia

DRUGS. 2003; 63 (10): 953-969

106

Date / Author / Journal

LCS

GCS

LCR

4381

4381 Chapman TM, Keating GM

Basifiximab - A review of its use as induction therapy in renal transplantation

DRUGS. 2003; 63 (24): 2803-2835

4382

4382 Ensminger SM, Spriewald BM, Fischlein T, Weyand M, Morris PJ, et al.

Mouse endothelial CD40 expression does not play a role during the development of transplant arteriosclerosis

ENDOTHELIUM-NEW YORK. 2003; 10 (2): 111-117

4383

4383 Arai K

Genetics of the loach, Misgurnus anguillicaudatus: recent progress and perspective

FOLIA BIOLOGICA-KRAKOW. 2003; 51: 107-117

4384

4384 Nakagawa M, Ueno K

Pigmentation in chimeric loach produced by cell transplantation with genetically pigmented and orange embryos

FOLIA BIOLOGICA-KRAKOW. 2003; 51: 119-123

4385

4385 Reisner Y, Gur H, Reich-Zeliger S, Martelli MF, Bachar-Lustig E

Hematopoietic stem cell transplantation across major genetic barriers - Tolerance induction by megadose CD34 cells and other veto cells

HEMATOPOIETIC STEM CELLS 2002: GENETICS AND FUNCTION. 2003; 996: 72-79

4386

4386 Theodoro A, Barreto CB, Gusmao PM, Von Held J, Cruz AD, et al.

Influence of first-wave derived T lymphocytes in the long term functional reconstitution of allogeneic T cell deficient hosts

IMMUNOBIOLOGY. 2003; 207 (3): 207-215

4387

4387 Maris M, Storb R

The transplantation of hematopoietic stem cells after non-myeloablative conditioning - A cellular therapeutic approach to hematologic and genetic diseases

IMMUNOLOGIC RESEARCH. 2003; 28 (1): 13-24

4388

4388 Ageyama N, Kimikawa M, Eguchi K, Ono F, Shibata H, et al.

Modification of the leukapheresis procedure for use in rhesus monkeys (Macaca mulata)

JOURNAL OF CLINICAL APHERESIS. 2003; 18 (1): 26-31

4389

4389 Kvasnicka HM, Wickenhauser C, Thiele J, Varus E, Hamm K, et al.

Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia

LEUKEMIA & LYMPHOMA. 2003; 44 (2): 321-328

4390

4390 Buno I, Anta B, Moreno-Lopez E, Balsalobre P, Balas A, et al.

Lineage-specific chimaerism quantification after T-cell depleted peripheral blood stem cell transplantation

LEUKEMIA & LYMPHOMA. 2003; 44 (4): 659-667

Date / Author / Journal

LCS

GCS

LCR

4391

4391 Juliusson G, Karlsson K, Malm C, Frodin U, Mollen AS, et al.

Adjusted conditioning for allogeneic transplantation in a single center setting: Mixed chimerism heralds relapse

LEUKEMIA & LYMPHOMA. 2003; 44 (4): 669-679

4392

4392 Kolar GR, Capra JD

The NOD/SCID chimeric mouse model of human B cell development: studies on the VH4 family immunoglobulin repertoire and implications for SLE

LUPUS. 2003; 12 (3): 158-162

4393

4393 Carpenter PA, Sanders JE

Steroid-refractory graft-vs.-host disease: past, present and future

PEDIATRIC TRANSPLANTATION. 2003; 7: 19-31

4394

4394 Spitzer TR

The expanding applications of non-myeloablative stem cell transplantation

PEDIATRIC TRANSPLANTATION. 2003; 7: 95-100

4395

4395 Hasegawa T, Imai H, Miki S

Cost evaluation of basiliximab treatment for renal transplant patients in Japan

PHARMACOECONOMICS. 2003; 21 (11): 791-806

4396

4396 Down JD, White-Scharf ME

Reprogramming immune responses: Enabling cellular therapies and regenerative medicine

STEM CELLS. 2003; 21 (1): 21-32

111

4397

4397 Askenasy N, Yoleuk ES, Shirwan H, Wang ZL, Farkas DL

Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients

STEM CELLS. 2003; 21 (2): 200-207

4398

4398 Nitsche A, Junghahn I, Thulke S, Aumann J, Radonic A, et al.

Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice

STEM CELLS. 2003; 21 (2): 236-244

4399

4399 Shields LE, Gaur LK, Gough M, Potter J, Sieverkropp A, et al.

In utero hematopoietic stem cell transplantation in nonhuman primates: The role of T cells

STEM CELLS. 2003; 21 (3): 304-314

4400

4400 Zorina TD, Subbotin VM, Bertera S, Alexander AM, Haluszczak C, et al.

Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes

STEM CELLS. 2003; 21 (4): 377-388

Chimerism and Transplantation topic search 8998 papers downloaded from Web of Science. Topic=((chimer* OR microchimer) AND (graft OR allograft* OR homograft* OR transplant*)) Timespan=1950-01-01 - 2011-12-31. Databases=SCI-EXPANDED, SSCI, A&HCI. Lemmatization=Off AND 85 papers added from the cited references list.	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011
List of All Records